After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Channing Paller discussing germline and somatic genetic ...
WBAL-TV on MSN
You may not know CHEK2. Here's why you should
Katharine Bisordi, a genetic counselor at Mercy Medical Center in Baltimore, said not everyone with CHEK2 will have the same ...
The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Aurelius Omlin discussing optimized use of immunotherapy and targeted ...
It is estimated that AI is answering around 2.5 million prompts per day – but what happens when you ask about the devastating ...
Federal funding has long played a crucial role in supporting research at Duke, a point underscored in a 1989 letter to the ...
Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk ...
It’s been a busy week in the life sciences! Discover the latest developments below in this edition of Week in […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback